Aktiesnakken — Marts 2010
-
upsides to guidance
-
metrics ie no of patients treated
-
doubble digit numbers contacted genmab about the company
-
hintede eatwell at arzerra vil få samme milestone for EU godkendelse som US godkendelse?
-
også foran min
-
more information - din bitch - du har ikke givet nogen overhovedet
-
sagde de ikke at de havde haft en stor interesse angående fabrikken
-
mange hits på nettet, og double digit mht kontakter, og de var kommet godt fra start med salget
-
hvor mange hospitaler er på arzerra i US
-
hun vil virkelig ikke ud med nogen info overhovedet!
-
RA subcutan - ingen information
-
hvorfor overhovedet have Q&A
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind